BBIO logo

BBIO
BridgeBio Pharma Inc

5,353
Mkt Cap
$12.85B
Volume
4.13M
52W High
$69.48
52W Low
$25.34
PE Ratio
-16.27
BBIO Fundamentals
Price
$69.22
Prev Close
$64.62
Open
$64.64
50D MA
$57.81
Beta
1.38
Avg. Volume
2.53M
EPS (Annual)
-$2.88
P/B
-6.79
Rev/Employee
$303,975.34
Loading...
Loading...
News
all
press releases
Eagle Health Investments LP Invests $11.20 Million in BridgeBio Pharma, Inc. $BBIO
Eagle Health Investments LP acquired a new position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) in the second quarter, according to its most recent filing with the Securities...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Ensign Peak Advisors Inc Sells 534,060 Shares of BridgeBio Pharma, Inc. $BBIO
Ensign Peak Advisors Inc lowered its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 28.9% in the second quarter, according to its most recent 13F filing with the Securities...
MarketBeat·1d ago
News Placeholder
BridgeBio Pharma (NASDAQ:BBIO) Director Sells $666,500.00 in Stock
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) Director Randal Scott sold 10,000 shares of BridgeBio Pharma stock in a transaction dated Monday, November 17th. The stock was sold at an...
MarketBeat·2d ago
News Placeholder
Insider Selling: BridgeBio Pharma (NASDAQ:BBIO) Director Sells 40,599 Shares of Stock
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) Director Andrew Lo sold 40,599 shares of the company's stock in a transaction dated Monday, November 17th. The shares were sold at an average...
MarketBeat·2d ago
News Placeholder
BridgeBio Pharma (NASDAQ:BBIO) Director Sells $3,612,950.00 in Stock
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) Director Andrew Lo sold 55,000 shares of BridgeBio Pharma stock in a transaction dated Tuesday, November 18th. The shares were sold at an...
MarketBeat·2d ago
News Placeholder
BridgeBio Pharma, Inc. $BBIO Shares Sold by KBC Group NV
KBC Group NV lowered its position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 98.0% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned...
MarketBeat·2d ago
News Placeholder
Savant Capital LLC Acquires Shares of 5,051 BridgeBio Pharma, Inc. $BBIO
Savant Capital LLC bought a new position in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and...
MarketBeat·2d ago
News Placeholder
Envestnet Asset Management Inc. Boosts Position in BridgeBio Pharma, Inc. $BBIO
Envestnet Asset Management Inc. grew its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 204.1% in the 2nd quarter, according to the company in its most recent disclosure...
MarketBeat·2d ago
News Placeholder
BridgeBio Pharma (NASDAQ:BBIO) CFO Sells $1,125,433.64 in Stock
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) CFO Thomas Trimarchi sold 16,934 shares of the stock in a transaction on Monday, November 17th. The stock was sold at an average price of...
MarketBeat·2d ago
News Placeholder
BridgeBio Pharma (NASDAQ:BBIO) CFO Thomas Trimarchi Sells 16,934 Shares
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) CFO Thomas Trimarchi sold 16,934 shares of the stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average...
MarketBeat·3d ago

Latest BBIO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.